Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...
Research has demonstrated the negative consequences of excessive added sugar intake, yet the government continues to support ...
Many existing and proposed regulations are now under fire and face rollbacks. But the new administration's pick to lead ...
Robert F. Kennedy Jr. has said vaccines are not safe. His support for abortion access has made conservatives uncomfortable.
The FDA, which has stopped short of requiring DPYD testing for patients before receiving fluoropyrimidines, emphasized the ...
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...
FDA Restructures its Food Resources Although there were a number of significant new regulations, the most significant food ...
After 20 years of hemming, hawing, and “evaluating the science,” the FDA is finally muscling its way onto the most coveted ...
The US Food and Drug Administration announced this month that it's effectively banning Red No. 3, the controversial ...
Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...
Most adults in the United States drink alcohol, but there is steadily growing public concern about the health effects of ...
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback